Genezen fast tracks second phase expansion in US

URLhttps://bioprocessintl.com/bioprocess-insider/faci
SourceBio Process International
Date Published04/28/2022
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Genezen
Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2022
Domestically, the work will be done:In-house
City reshored to:Indianapolis
State(s) reshored to:IN
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshoredgene therapy CDMO
What domestic positive factors made reshoring more attractive?Lead time/Time to market
Find Reshoring Articles